ACONW | Aclarion, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0362 - 0.0400
52 Week Range	0.0362 - 0.0400
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	9,198
Average Volume	N/A
Shares Outstanding	45,277,369
Market Cap	1,811,095
Sector	Healthcare
Industry	Medical - Healthcare Information Services
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	-0.01
Forward P/E Ratio	N/A
EPS	-6.58
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	4
Country	USA
Website	ACONW

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

ACONW's peers: RNLX, IVDAW, EDBLW, ACON, DRMAW, BEATW, MGRX

*Chart delayed

Analyzing fundamentals for ACONW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see ACONW Fundamentals page.

Watching at ACONW technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ACONW Technicals page.